相关临床试验
55
12 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1992
进行中（未招募）
7
12.7%
已完成
33
60.0%
Enrolling By Invitation
2
3.6%
尚未招募
3
5.5%
招募中
6
10.9%
终止
1
1.8%
Unknown
3
5.5%
暂无批准数据
- The STAMINA lifestyle intervention reduced deterioration in quality of life by as much as one-third in men receiving androgen deprivation therapy for prostate cancer, researchers reported in The Lancet Oncology. - In the 700-patient UK trial across 15 NHS hospitals, more than 80% of participants attended scheduled supervised exercise sessions over the 12-month study period. - Economic modelling showed the program costs well below standard NHS thresholds for cancer interventions and is expected to remain cost-effective for up to a decade. - Nuffield Health has launched a Cancer Activity Programme based on STAMINA, committing to fund 50,000 places by 2030 with planned expansion to breast and bowel cancer.
- Researchers at Sheffield Hallam University discovered that combining scalp cooling with antioxidants like N-Acetylcysteine or Resveratrol significantly reduces chemotherapy-induced hair follicle damage. - The study found optimal cooling at 18°C prevents hair loss, while sub-optimal cooling at 26°C combined with antioxidants provides comparable protection. - This breakthrough could transform scalp cooling into a more consistent treatment for the 65% of chemotherapy patients who experience hair loss. - The combined approach effectively reduces reactive oxygen species production, addressing a key mechanism of chemotherapy-induced hair follicle damage.
